Showing results (1-10 of 79) with videos related to
Sort By:
Pageof 8
Expert Review of Anticancer Therapy|December 22, 2006
Targeted therapies in metastatic renal cell carcinoma: the light at the end of the tunnelDamien Pouessel, Stéphane CulineEuropean Urology|September 11, 2007
High frequency of intracerebral hemorrhage in metastatic renal carcinoma patients with brain metastases treated with tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptorDamien Pouessel, Stéphane CulineAnti-Cancer Drugs|September 22, 2011
Complete clinical and biological response to zoledronic acid in castrate-resistant prostate cancer metastatic to boneDamien Pouessel, Stéphane CulineBulletin Du Cancer|November 6, 2007
[Angiogenesis targeting in renal carcinomas]Damien Pouessel, Stephane CulineBulletin Du Cancer|November 14, 2008
[Towards the individualisation of prescriptions in oncology: urogenital cancers]Damien Pouessel, Stéphane CulineCritical Reviews in Oncology/Hematology|October 2, 2012
Neoadjuvant chemotherapy in muscle-invasive bladder cancer: ready for prime time?Damien Pouessel, Pierre Mongiat-Artus, Stéphane CulineCurrent Opinion in Supportive and Palliative Care|August 8, 2008
New therapies in renal cell carcinomaJean-Jacques Patard, Damien Pouessel, Stéphane CulineExpert Review of Anticancer Therapy|June 20, 2020
Abiraterone acetate in combination with prednisone in the treatment of prostate cancer: safety and efficacyCécile Manceau, Loic Mourey, Damien Pouessel, et al.Case Reports in Oncology|March 26, 2013
Abiraterone acetate withdrawal syndrome: does it exist?Hélène Gauthier, Guilhem Bousquet, Damien Pouessel, et al.World Journal of Urology|February 13, 2008
Targeted therapy in renal cell carcinomaJean-Jacques Patard, Damien Pouessel, Karim Bensalah, et al.Pageof 8